hledat

Vaše výsledky

Zobrazuje se 10 z 18 výsledky

Nanoparticles lie at the heart of a new method for delivering medicines inside the body – and they were crucial to the success of the Covid-19 mRNA vaccines. This new drug delivery method and others could transform the way we treat disease, potentially boosting the treatment of Alzheimer's, Parkinson's and HIV, among others. Insulin and Covid-19 vaccines might even become available as pills. Can the European Union stay on top of this trend? And what challenges lie ahead?

Ten technologies to fight coronavirus

Podrobná analýza 22-04-2020

From synthetic biology to artificial intelligence and from blockchain technologies to nanotechnology, a wide range of technological applications are being deployed to combat COVID-19. Are they safe and effective? Have they been tested before in a public health emergency context? Does their use involve risks and threaten our values and rights? This well-timed STOA publication of ten central technological trajectories employed in the fight against this pandemic disease offers us a much-needed analysis ...

Through developments in the field of metamaterials, we may be able to create products with surprising capabilities, from making DNA visible to making buildings invisible, but have we considered the risks, as well as the benefits?

Speeding up authorisation of novel foods

Ve stručnosti 20-10-2015

In December 2013, the European Commission presented a proposal to clarify the definition of novel foods, take into account new technologies in food-making, and streamline and speed up the authorisation process. The proposal also seeks to make it easier for traditional foods from countries outside the European Union (EU) to enter the EU market. A compromise following negotiations in trilogue is awaiting a vote in the October III plenary session.

To protect public health, new foods or food ingredients ('novel foods') require safety assessment and authorisation before they can be placed on the EU market. The current authorisation process covering novel foods is seen by the food industry as complex, expensive and time-consuming. In addition, stakeholders agree that updating the current Novel Foods Regulation, which dates back to 1997, is urgently needed to reflect scientific and technological advances. In December 2013, the Commission ...

In February 2013, the European Union (EU) and the United States of America (US) started the procedures necessary for initiating formal negotiations on a free trade agreement, referred to as the “Transatlantic Trade and Investment Partnership” (TTIP). The first round of negotiations took place in Washington D.C. in July 2013, the seventh round ended on 3 October 2014 and the eight round is taking place in Brussels from 2 to 6 February 2015. In order to monitor the on-going negotiations, the Committee ...

This study, prepared by Policy Department A, aims to support Members of the Committee on Environment, Public Health and Food Safety (ENVI) in monitoring on-going negotiations for a Transatlantic Trade and Investment Partnership (TTIP). It analyses the main differences between EU and US legislation in eight areas, namely: human medicines and medical devices, cosmetics, food and nutrition, sanitary and phyto-sanitary, nanomaterials, cloning, raw materials and energy, and motor vehicles. Existing collaboration ...

Key Enabling Technologies (KETs) are crucial for the competitiveness and renewal of European manufacturing. This study, prepared by Policy Department A at the request of the Committee on Industry, Research and Energy (ITRE), examines the nature of KETs, the drivers and barriers to KETs deployment. It includes an assessment of the current KETs situation in the EU in a global perspective. A broad overview of European policies and financing instruments precedes an in-depth assessment of the role of ...

Food safety seeks to strike a balance between guaranteeing a high level of public health, environmental and consumer protection, while at the same time providing a stable regulatory environment for actors in the food chain. Food safety challenges relate to cross-cutting issues such as globalisation and climate change, as well as to specific cases – e.g. persistent episodes of food borne illness, Endocrine Disruptors and nanotechnology, particularly in the context of current and future regulation ...

Non-tariff barriers and regulatory divergence are considered as the main challenge for a potential comprehensive EU-US trade and investment agreement. Stemming from different values, public preferences and different approaches towards risk management, these regulatory issues are greatest in the fields of protection of health, safety and the environment. Efforts in transatlantic regulatory cooperation date back to the 1990s, but progress has been difficult to achieve.